Literature DB >> 22085534

Spinal muscular atrophy: clinical validation of a single-tube multiplex real time PCR assay for determination of SMN1 and SMN2 copy numbers.

Bruno Maranda1, Li Fan, Jean-François Soucy, Louise Simard, Grant A Mitchell.   

Abstract

OBJECTIVES: To describe and validate a new protocol for molecular diagnosis of spinal muscular atrophy (SMA), a frequent neuromuscular disease of childhood. DESIGN AND METHODS: SMA is caused in most cases by homozygous deletion of the SMN1 gene. We describe a triplex quantitative real-time PCR method in which fragments of SMN1, SMN2 (a nearly-identical neighboring gene with markedly reduced function) and of a control gene, CFTR, are amplified in the same tube.
RESULTS: We validated this method in three ways. First, testing the same samples ten times yielded CV values <4.6%. Second, in 104 previously-genotyped individuals, SMN copy numbers identical to those of the previously-determined genotype was unambiguously obtained in all cases. Finally, results using the technique in practice are described and analyzed for reproducibility of amplification efficiency and for inter-run variability.
CONCLUSIONS: In over 1200 samples, this technique has proven accurate, fast, economical and reproducible.
Copyright © 2011. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22085534     DOI: 10.1016/j.clinbiochem.2011.10.019

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  6 in total

1.  Carrier screening for spinal muscular atrophy with a simple test based on melting analysis.

Authors:  Zhongmin Xia; Yulin Zhou; Dongmei Fu; Zengge Wang; Yunsheng Ge; Jun Ren; Qiwei Guo
Journal:  J Hum Genet       Date:  2019-02-15       Impact factor: 3.172

2.  Colorimetric Assay for Exon 7 SMN1/SMN2 Single Nucleotide Polymorphism Using Gold Nanoprobes.

Authors:  Hossein Ahmadpour-Yazdi; Mohammad Hormozi-Nezhad; Ali Abadi; Mohammad Hossein Sanati; Bahram Kazemi
Journal:  Bioimpacts       Date:  2013-12-28

3.  Molecular Analysis of Spinal Muscular Atrophy: A genotyping protocol based on TaqMan(®) real-time PCR.

Authors:  Fernanda Marques de Souza Godinho; Hugo Bock; Tailise Conte Gheno; Maria Luiza Saraiva-Pereira
Journal:  Genet Mol Biol       Date:  2012-12-18       Impact factor: 1.771

4.  Molecular characterization and copy number of SMN1, SMN2 and NAIP in Chinese patients with spinal muscular atrophy and unrelated healthy controls.

Authors:  Ping Fang; Liang Li; Jian Zeng; Wan-Jun Zhou; Wei-Qing Wu; Ze-Yan Zhong; Ti-Zhen Yan; Jian-Sheng Xie; Jing Huang; Li Lin; Ying Zhao; Xiang-Min Xu
Journal:  BMC Musculoskelet Disord       Date:  2015-02-07       Impact factor: 2.362

5.  Assessment of Spinal Muscular Atrophy Carrier Status by Determining SMN1 Copy Number Using Dried Blood Spots.

Authors:  Yogik Onky Silvana Wijaya; Jamiyan Purevsuren; Nur Imma Fatimah Harahap; Emma Tabe Eko Niba; Yoshihiro Bouike; Dian Kesumapramudya Nurputra; Mawaddah Ar Rochmah; Cempaka Thursina; Sunartini Hapsara; Seiji Yamaguchi; Hisahide Nishio; Masakazu Shinohara
Journal:  Int J Neonatal Screen       Date:  2020-05-29

6.  SRSF1-dependent nuclear export inhibition of C9ORF72 repeat transcripts prevents neurodegeneration and associated motor deficits.

Authors:  Guillaume M Hautbergue; Lydia M Castelli; Laura Ferraiuolo; Alvaro Sanchez-Martinez; Johnathan Cooper-Knock; Adrian Higginbottom; Ya-Hui Lin; Claudia S Bauer; Jennifer E Dodd; Monika A Myszczynska; Sarah M Alam; Pierre Garneret; Jayanth S Chandran; Evangelia Karyka; Matthew J Stopford; Emma F Smith; Janine Kirby; Kathrin Meyer; Brian K Kaspar; Adrian M Isaacs; Sherif F El-Khamisy; Kurt J De Vos; Ke Ning; Mimoun Azzouz; Alexander J Whitworth; Pamela J Shaw
Journal:  Nat Commun       Date:  2017-07-05       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.